 |
| |
There are no Special Features!
|
|
|  |  |  |  | | | Subcommittee on Income Security and Family Support
***NOTICE — POSTPONED HEARING - RESCHEDULED***Hearing on the Utilization of Psychotropic Medication for Children in Foster Care
| Hearing Advisory | | | McDermott Announces Hearing on the Utilization of Psychotropic Medication for Children in Foster Care
| | | Witness List and Testimony (Printer Friendly)
| Witnesses | | Panel: | | | Julie M. Zito, Ph. D., Professor of Pharmacy and Psychiatry, Pharmaceutical Health Services Research, University of Maryland, Baltimore | | | Jeffery Thompson, M.D., Medical Director, Washington State Department of Social and Health Services, Olympia, Washington | | | Tricia Lea, Ph.D., Director of Medical and Behavioral Services, Department of Children’s Services, State of Tennessee | | | Misty Stenslie, Deputy Director, Foster Care Alumni of America | | | Laurel K. Leslie, Developmental-Behavioral Pediatrician, Center on Child and Family Outcomes, Tufts-New England Medical Center Institute for Clinical Research and Health Policy Studies | | | Christopher Bellonci, M.D., Medical Director, The Walker School, Needham, Massachusetts |
| | Submissions for the Record | | Hearing Transcript | | | Committee on Ways and Means, Subcommittee on Income Security and Family Support, 110-83, Hearing on the Utilization of Psychotropic Medication for Children in Foster Care
| | Printed Hearing | | | Not Yet Available | | |
| | |
